Treatment and survival differences in older medicare patients with lung cancer as compared with those who are dually eligible for medicare and medicaid

Journal of Clinical Oncology

Volumn 26, Issue 31, 2008, Pages 5067-5073

  Bradley, Cathy J ^a   Dahman, Bassam ^a   Given, Charles W ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CONTROLLED STUDY; ELDERLY CARE; FEMALE; HEALTH CARE FINANCING; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SOCIAL STATUS;

AFRICAN AMERICANS; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; ELIGIBILITY DETERMINATION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; INSURANCE COVERAGE; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MEDICAID; MEDICARE; MICHIGAN; PNEUMONECTOMY; RADIOTHERAPY; REGISTRIES; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 55549095659     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.16.3071     Document Type: Article

References (25)

1. Edwards B, Brown M, Wingo P, et al: Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97:1407-1427, 2005
2. Bradley C, Given C, Luo Z, et al: Cancer incidence in elderly Medicare and dual eligible beneficiaries. Health Serv Res [epub ahead of print on May 12, 2008]
3. Sullivan V, Tran T, Holmstrom A, et al: Advanced age does not exclude lobectomy for non-small cell lung carcinoma. Chest 128:2671-2676, 2005
4. Winton T, Livingston R, Johnson D, et al: Vinorelbine plus cisplatin vs. observation in resected non-small cell lung cancer. N Engl J Med 352:2589-2597, 2005
5. Arriagada R, Bergman B, Dunant A, et al: Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. N Engl J Med 350:351-360, 2004
6. Visbal A, Leigh N, Feld R, et al: Adjuvant chemotherapy for early-stage non-small cell lung cancer. Chest 128:2933-2943, 2005
7. Birim O, Kappetein P, Goorden T, et al: Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer. Ann Thorac Surg 80:1021-1026, 2005
8. Wisnivesky J, Bonomi M, Henschke C, et al: Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer. Chest 128: 1461-1467, 2005
9. Earle C, Neumann P, Gelber R, et al: Impact of referral patterns on the use of chemotherapy for lung cancer. J Clin Oncol 20:1786-1792, 2002
10. Bach P, Cramer L, Warren J, et al: Racial differences in the treatment of early-stage lung cancer. N Engl J Med 341:1198-1205, 1999
11. Lathan C, Neville B, Earle C: The effect of race on invasive staging and surgery in non-small cell lung cancer. J Clin Oncol 24:413-418, 2006
12. Earle C, Venditti L, Neumann P, et al: Who gets chemotherapy for metastatic lung cancer? Chest 117:1239-1246, 2000
13. Potosky A, Saxman S, Wallace R, et al: Population variations in the initial treatment of non-small-cell lung cancer. J Clin Oncol 22:3261-3268, 2004
14. Medicare Payment Advisory Commission (Med-PAC): Analysis of Medicare Current Beneficiary Survey (MCBS), 2001. http://www.medpac.gov/publications/ congressional_reports/Jun04DatabookSec2.pdf
15. Murray L, Shatto A: Dually eligible Medicare beneficiaries. Health Care Financ Rev 20:131-140, 1998
16. Department of Health and Human Services, Centers for Medicare and Medicaid Services, Center for Medicaid and State Operations: Medicaid-at-a-glance 2005. http://www.cms.hhs.gov/MedicaidEligibility/Downloads/ MedicaidataGlance05.pdf
17. Bradley C, Given C, Luo Z, et al: Medicaid, Medicare, and the Michigan Tumor Registry: A Linkage Strategy. Med Decis Making 27:352-363, 2007
18. Allison PD: Missing Data. Thousand Oaks, CA, Sage Publications, 2001
19. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45:613-619, 1992
20. Klabunde CE, Potosky AL, Legler JM, et al: Development of a comorbidity index using physician claims data. J Clin Epidemiol 53:1258-1267, 2000
21. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40:373-383, 1987
22. Baldwin LM, Klabunde CE, Green P, et al: In search of the perfect comorbidity measure for use with administrative claim data: Does it exist? Med Care 44:745-753, 2006
23. Pezzin LE, Kasper JD: Medicaid enrollment among elderly Medicare beneficiaries: Individual determinants, effects of state policy, and impact on service use. Health Serv Res 37:827-847, 2002
24. Froehner M, Koch R, Litz R, et al: Comparison of the American Society of Anesthesiologists physical status classification with the Charlson score as predictors of survival after radical prostatectomy. Urology 62:698-701, 2003
25. Extermann M: Measuring comorbidity in older cancer patients. Eur J Cancer 36:453-471, 2000